Publication Cover
Spectroscopy Letters
An International Journal for Rapid Communication
Volume 23, 1990 - Issue 7
7
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Mass Spectroscopy of the Antileukemic Drug MGBG and Related Bis(Amidinohydrazones) [‘Bis(Guanylhydrazones)’]

, &
Pages 865-876 | Received 04 Apr 1990, Accepted 05 May 1990, Published online: 24 Oct 2006
 

Abstract

The first study on the mass spectroscopy of various bis(amidinohydrazones) is reported. The compounds studied included the investigational antileukemic drugs methylglyoxal bis(amidino-hydrazone) [‘methylglyoxal bis(guanylhydrazone)’, MGBG] and glyoxal bis(amidinohydrazone), as well as seven mono- and dialkylglyoxal analogs thereof. The results indicate that the free bases of these high-melting compounds are volatilized well enough to allow a facile detection of the molecular ions and to make mass spectroscopy of the underivatized compounds a suitable method for the verification of the identity of the substances. This result is of importance considering the development of novel analogs and derivatives. A compilation of electron-impact mass spectra is reported and possible fragmentation routes are outlined. The fragmentation of the various congeners appears to occur essentially similarly, the main paths involving breakage of the carbon-carbon single bond in the glyoxal moiety or breakage of either one of the nitrogen-nitrogen single bonds.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.